A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AZD5148 FOR PREVENTION OF RECURRENCE OF CLOSTRIDIOIDES DIFFICILE INFECTION IN INDIVIDUALS 18 YEARS OF AGE AND ABOVE

Registry ID

D8820C00003

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

ASTRAZENECA CANADA INC

Start date

2026-05-15

Last update

2025-10-10

Conditions

• CLOSTRIDIOIDES DIFFICILE

Related clinical trials

• SECONDARY PROPHYLAXIS OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION DURING SYSTEMIC ANTIBIOTICS WITH VANCOMYCIN (SPORES-V): A RANDOMIZED CONTROLLED TRIAL
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VE303 FOR PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: THE RESTORATIVE303 STUDY
• LYOPHILIZED FECAL MICROBIOME TRANSFER FOR PRIMARY CLOSTRIDIOIDES DIFFICILE INFECTION (DONATE STUDY): A MULTICENTER RANDOMIZED CONTROLLED TRIAL

View on source registry